GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Concord Healthcare Group Co Ltd (HKSE:02453) » Definitions » PE Ratio

Concord Healthcare Group Co (HKSE:02453) PE Ratio : At Loss (As of Dec. 13, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Concord Healthcare Group Co PE Ratio?

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-12-13), Concord Healthcare Group Co's share price is HK$13.98. Concord Healthcare Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-0.54. Therefore, Concord Healthcare Group Co's PE Ratio for today is At Loss.

Concord Healthcare Group Co's EPS (Diluted) for the six months ended in Jun. 2024 was HK$-0.27. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-0.54.

As of today (2024-12-13), Concord Healthcare Group Co's share price is HK$13.98. Concord Healthcare Group Co's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-0.65. Therefore, Concord Healthcare Group Co's PE Ratio without NRI ratio for today is At Loss.

Concord Healthcare Group Co's EPS without NRI for the six months ended in Jun. 2024 was HK$-0.34. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-0.65.

During the past 3 years, the average EPS without NRI Growth Rate was 13.40% per year.

During the past 4 years, Concord Healthcare Group Co's highest 3-Year average EPS without NRI Growth Rate was 13.40% per year. The lowest was 13.40% per year. And the median was 13.40% per year.

Concord Healthcare Group Co's EPS (Basic) for the six months ended in Jun. 2024 was HK$-0.27. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-0.54.

Back to Basics: PE Ratio


Concord Healthcare Group Co PE Ratio Historical Data

The historical data trend for Concord Healthcare Group Co's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Healthcare Group Co PE Ratio Chart

Concord Healthcare Group Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
PE Ratio
N/A N/A N/A N/A

Concord Healthcare Group Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
PE Ratio Get a 7-Day Free Trial At Loss N/A At Loss N/A At Loss

Competitive Comparison of Concord Healthcare Group Co's PE Ratio

For the Medical Care Facilities subindustry, Concord Healthcare Group Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Concord Healthcare Group Co's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Concord Healthcare Group Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Concord Healthcare Group Co's PE Ratio falls into.



Concord Healthcare Group Co PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Concord Healthcare Group Co's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=13.98/-0.542
=-25.79(At Loss)

Concord Healthcare Group Co's Share Price of today is HK$13.98.
For company reported semi-annually, Concord Healthcare Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.54.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Concord Healthcare Group Co  (HKSE:02453) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Concord Healthcare Group Co PE Ratio Related Terms

Thank you for viewing the detailed overview of Concord Healthcare Group Co's PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Concord Healthcare Group Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 7 Guanghua Road, Room 26A1-26A5, East Tower, Hanwei Building, Chaoyang, Beijing, CHN, 100020
Concord Healthcare Group Co Ltd is a healthcare service provider in China that specializes in oncology. The company caters to both cancer patients and third-party medical institutions. It operates its own medical institutions to provide comprehensive oncology healthcare services to cancer patients using its medical professionals and advanced precision radiation therapy. It also provides medical equipment, software, and related services to third-party medical institutions. The company's revenue is primarily generated from its hospital business and its medical equipment, software, and related services segment.
Executives
China International Capital Corporation Limited
Zhong Jin Zi Ben Yun Ying You Xian Gong Si
Zhong Jin Jia Tai Er Qi Tian Jin Gu Quan Tou Zi Ji Jin He Huo Qi Ye You Xian He Huo
Ascendium Group Limited
Concord Medical Services Holdings Limited
Morgancreek Investment Holdings Limited
Yang Jianyu
Zhang Bi
Beijing Concord Medical Technology Co., Ltd.
Concord Hospital Management Group Limited
Shanghai Medstar Financial Leasing Company Limited
Tianjin Concord Medical Technology Co., Ltd.

Concord Healthcare Group Co Headlines

No Headlines